128 related articles for article (PubMed ID: 11457654)
1. Active efflux of the 5-HT(1A) receptor agonist flesinoxan via P-glycoprotein at the blood-brain barrier.
van der Sandt IC; Smolders R; Nabulsi L; Zuideveld KP; de Boer AG; Breimer DD
Eur J Pharm Sci; 2001 Aug; 14(1):81-6. PubMed ID: 11457654
[TBL] [Abstract][Full Text] [Related]
2. Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood--brain barrier.
van der Sandt IC; Vos CM; Nabulsi L; Blom-Roosemalen MC; Voorwinden HH; de Boer AG; Breimer DD
AIDS; 2001 Mar; 15(4):483-91. PubMed ID: 11242145
[TBL] [Abstract][Full Text] [Related]
3. The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone.
Karssen AM; Meijer OC; van der Sandt IC; De Boer AG; De Lange EC; De Kloet ER
J Endocrinol; 2002 Oct; 175(1):251-60. PubMed ID: 12379510
[TBL] [Abstract][Full Text] [Related]
4. Blonanserin, a novel atypical antipsychotic agent not actively transported as substrate by P-glycoprotein.
Inoue T; Osada K; Tagawa M; Ogawa Y; Haga T; Sogame Y; Hashizume T; Watanabe T; Taguchi A; Katsumata T; Yabuki M; Yamaguchi N
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):156-62. PubMed ID: 22691713
[TBL] [Abstract][Full Text] [Related]
5. The antiepileptic drug mephobarbital is not transported by P-glycoprotein or multidrug resistance protein 1 at the blood-brain barrier: a positron emission tomography study.
Mairinger S; Bankstahl JP; Kuntner C; Römermann K; Bankstahl M; Wanek T; Stanek J; Löscher W; Müller M; Erker T; Langer O
Epilepsy Res; 2012 Jun; 100(1-2):93-103. PubMed ID: 22342565
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin.
de Lange EC; Marchand S; van den Berg D; van der Sandt IC; de Boer AG; Delon A; Bouquet S; Couet W
Eur J Pharm Sci; 2000 Dec; 12(2):85-93. PubMed ID: 11102735
[TBL] [Abstract][Full Text] [Related]
7. Stress-induced hyperthermia in the 5-HT(1A) receptor knockout mouse is normal.
Pattij T; Hijzen TH; Groenink L; Oosting RS; van der Gugten J; Maes RA; Hen R; Olivier B
Biol Psychiatry; 2001 Apr; 49(7):569-74. PubMed ID: 11297713
[TBL] [Abstract][Full Text] [Related]
8. Investigation of MDR1-overexpressing cell lines to derive a quantitative prediction approach for brain disposition using in vitro efflux activities.
Sato S; Tohyama K; Kosugi Y
Eur J Pharm Sci; 2020 Jan; 142():105119. PubMed ID: 31682973
[TBL] [Abstract][Full Text] [Related]
9. Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza Bunge widely used in the treatment of stroke and Alzheimer's disease, across the blood-brain barrier.
Yu XY; Lin SG; Chen X; Zhou ZW; Liang J; Duan W; Chowbay B; Wen JY; Chan E; Cao J; Li CG; Zhou SF
Curr Drug Metab; 2007 May; 8(4):365-78. PubMed ID: 17504224
[TBL] [Abstract][Full Text] [Related]
10. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines.
van der Sandt IC; Blom-Roosemalen MC; de Boer AG; Breimer DD
Eur J Pharm Sci; 2000 Sep; 11(3):207-14. PubMed ID: 11042226
[TBL] [Abstract][Full Text] [Related]
11. Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP/MXR/ABCP on the transport of (99m)Tc-tetrofosmin.
Chen WS; Luker KE; Dahlheimer JL; Pica CM; Luker GD; Piwnica-Worms D
Biochem Pharmacol; 2000 Aug; 60(3):413-26. PubMed ID: 10856437
[TBL] [Abstract][Full Text] [Related]
12. Contribution of P-glycoprotein to bunitrolol efflux across blood-brain barrier.
Matsuzaki J; Yamamoto C; Miyama T; Takanaga H; Matsuo H; Ishizuka H; Kawahara Y; Kuwano M; Naito M; Tsuruo T; Sawada Y
Biopharm Drug Dispos; 1999 Mar; 20(2):85-90. PubMed ID: 10206323
[TBL] [Abstract][Full Text] [Related]
13. Is aspirin a substrate of MDR1/P-glycoprotein?
Singh R; Naik T; Nigam A; Chatterjee S; Rajanna P; Shen H; Iyer R
Xenobiotica; 2020 Oct; 50(10):1258-1264. PubMed ID: 32302241
[TBL] [Abstract][Full Text] [Related]
14. BBB transport and P-glycoprotein functionality using MDR1A (-/-) and wild-type mice. Total brain versus microdialysis concentration profiles of rhodamine-123.
de Lange EC; de Bock G; Schinkel AH; de Boer AG; Breimer DD
Pharm Res; 1998 Nov; 15(11):1657-65. PubMed ID: 9833984
[TBL] [Abstract][Full Text] [Related]
15. Blood-brain barrier (BBB) pharmacoproteomics: reconstruction of in vivo brain distribution of 11 P-glycoprotein substrates based on the BBB transporter protein concentration, in vitro intrinsic transport activity, and unbound fraction in plasma and brain in mice.
Uchida Y; Ohtsuki S; Kamiie J; Terasaki T
J Pharmacol Exp Ther; 2011 Nov; 339(2):579-88. PubMed ID: 21828264
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a 67Ga/68Ga radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo: validation in multidrug-resistant tumors and at the blood-brain barrier.
Sharma V; Prior JL; Belinsky MG; Kruh GD; Piwnica-Worms D
J Nucl Med; 2005 Feb; 46(2):354-64. PubMed ID: 15695797
[TBL] [Abstract][Full Text] [Related]
17. Evidence of P-glycoprotein mediated apical to basolateral transport of flunisolide in human broncho-tracheal epithelial cells (Calu-3).
Florea BI; van der Sandt IC; Schrier SM; Kooiman K; Deryckere K; de Boer AG; Junginger HE; Borchard G
Br J Pharmacol; 2001 Dec; 134(7):1555-63. PubMed ID: 11724763
[TBL] [Abstract][Full Text] [Related]
18. Effect of a 5-HT(1A) receptor agonist, flesinoxan, on the extracellular noradrenaline level in the hippocampus and on the locomotor activity of rats.
Suwabe A; Kubota M; Niwa M; Kobayashi K; Kanba S
Brain Res; 2000 Mar; 858(2):393-401. PubMed ID: 10708692
[TBL] [Abstract][Full Text] [Related]
19. Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein.
Adachi Y; Suzuki H; Sugiyama Y
Pharm Res; 2001 Dec; 18(12):1660-8. PubMed ID: 11785684
[TBL] [Abstract][Full Text] [Related]
20. Interaction of docetaxel ("Taxotere") with human P-glycoprotein.
Shirakawa K; Takara K; Tanigawara Y; Aoyama N; Kasuga M; Komada F; Sakaeda T; Okumura K
Jpn J Cancer Res; 1999 Dec; 90(12):1380-6. PubMed ID: 10665657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
